Clinical Trials
Social Phobia (Social Anxiety Disorder)
Featured Studies
Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the ClinicalTrials.gov registry, with the most recent studies appearing first.
- Effect of D-Cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia.
Interventional study. This study will assess the effectiveness of D-cycloserine combined with cognitive-behavior therapy in treating people with social anxiety disorder. Ages 18 and over. Location in Boston, MA.
- Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia.
Interventional study. This study will evaluate the effect of cognitive behavioral therapy on the brain during emotional and behavioral responses to social stimuli in people with social phobia. Ages 21-55. Location in Stanford, CA.
- Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder.
Interventional study. This study will compare the effectiveness of either adding clonazepam or placebo to standard treatment or switching to venlafaxine in treating generalized social anxiety disorder in individuals who have not responded to treatment with sertraline. Ages 18 and over. Locations in La Jolla, CA; Boston, MA; Hamilton, ON.
- Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia.
Interventional study. This study examines whether an antibiotic, d-cycloserine (DCS), boosts the effectiveness of cognitive behavior therapy (CBT) for social anxiety. Ages 7-55. Locations in Baltimore, MD; Bethesda, MD.
Search ClinicalTrials.gov for other NIH studies on Social Phobia (Social Anxiety Disorder).
